Ethical Considerations Pertaining To Aging

Dr. Stephen Shrewsbury
Presenter: Neal Howard
Guest: Dr. Stephen Shrewsbury
Guest Bio: Dr. Shrewsbury was most recently Senior Vice President, Preclinical & Clinical Development and Chief Medical Officer of AVI BioPharma (now Sarepta Therapeutics). From 2005 until 2009, he held similar roles at Adamas Pharmaceuticals and MAP Pharmaceuticals. While at MAP, Dr. Shrewsbury lead four inhaled drug programs and took two lead candidates (in asthma and migraine) from preclinical stage to Phase III in 18 months. Prior to his experience in biotechnology, Dr. Shrewsbury spent 10 years with Glaxo and Chiron launching notable respiratory programs such as Seretide in Europe and Flovent and Advair in the US. Dr. Shrewsbury received his medical degree from the University of Liverpool, UK and spent 13 years working in the UK National Health Service before entering the pharmaceutical industry.

Segment Overview
Dr. Stephen Shrewsbury discusses his book “Defy your DNA” and also further addresses ethical considerations pertaining to aging.



Transcription

Health Professional Radio

Neal Howard: Hello. You’re listening to Health Professional Radio. I’m your host, Neal Howard. Our guest in studio today is Dr. Steven Shrewsbury. He’s been doing research in gene patches. Gene patches are what Dr. Shrewsbury refers to as, well, molecular band-aids. What if medical science could stop cancer or other neuromuscular diseases dead in their tracks, or even protect us against the potential of biological weapons as we think about how the world scene is changing as it pertains to terrorism and warfare in general?

The author of Defy Your DNA, how are you doing today, Dr. Shrewsbury?

Want to continue reading? Please log-in or register to see the Full Transcript.

Liked it? Take a second to support healthprofessionalradio on Patreon!